Sign in
4

Changes in Ownership

Amneal Pharmaceuticals, Inc. Filed Acc 0001628280-25-010718

Executive Vice President gave up 145,342 shares (to pay taxes)

  • Executive Vice President acquired 284,144 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
BOYER ANDREW S Executive Vice President 2025-03-03 Option exercise +39,251 315,555 D
BOYER ANDREW S Executive Vice President 2025-03-03 Shares withheld for taxes −20,077 $8.76 $175,875 295,478 D
BOYER ANDREW S Executive Vice President 2025-03-03 Option exercise +49,694 345,172 D
BOYER ANDREW S Executive Vice President 2025-03-03 Shares withheld for taxes −25,419 $8.76 $222,670 319,753 D
BOYER ANDREW S Executive Vice President 2025-03-03 Option exercise +157,005 476,758 D
BOYER ANDREW S Executive Vice President 2025-03-03 Shares withheld for taxes −80,309 $8.76 $703,507 396,449 D
BOYER ANDREW S Executive Vice President 2025-03-04 Option exercise +38,194 434,643 D
BOYER ANDREW S Executive Vice President 2025-03-04 Shares withheld for taxes −19,537 $8.84 $172,707 415,106 D
Derivatives
BOYER ANDREW S Executive Vice President 2025-03-03 Option exercise · Restricted Stock Units −39,251 39,252 D
BOYER ANDREW S Executive Vice President 2025-03-03 Option exercise · Restricted Stock Units −49,694 99,389 D
BOYER ANDREW S Executive Vice President 2025-03-03 Option exercise · Performance-Based Restricted Stock Units −157,005 0 D
BOYER ANDREW S Executive Vice President 2025-03-03 Grant or award · Performance-Based Restricted Stock Units +194,064 194,064 D
BOYER ANDREW S Executive Vice President 2025-03-03 Grant or award · Restricted Stock Units +97,032 97,033 D
BOYER ANDREW S Executive Vice President 2025-03-04 Option exercise · Restricted Stock Units −38,194 114,582 D
Loading xslF345X05/wk-form4_1741223923.xml…